XML 41 R30.htm IDEA: XBRL DOCUMENT

SUPPLEMENTAL EQUITY INFORMATION (Tables)

6 Months Ended

Jun. 28, 2020

Schedule of components of accumulated other comprehensive loss, net of tax


			Other
	Minimum		Comprehensive
	Pension and		Loss
	Post-		Related to
	Retirement		Equity
(in thousands)	Liability		Investments		Total
Balance at December 29, 2019	$	(567,670)	$	(8,469)	$	(576,139)
Other comprehensive income (loss) before reclassifications		—		966		966
Amounts reclassified from AOCL		13,469		—		13,469
Other comprehensive income		13,469		966		14,435
Balance at June 28, 2020	$	(554,201)	$	(7,503)	$	(561,704)

Schedule of reclassification out of accumulated other comprehensive income


	Amount Reclassified from AOCL				Amount Reclassified from AOCL
	Quarters Ended				Six Months Ended
(in thousands)	June 28,		June 30,		June 28,		June 30,		Affected Line in the Condensed
AOCL Component	2020		2019		2020		2019		Consolidated Statements of Operations
Minimum pension and post-retirement liability	$	6,734	$	5,441	$	13,469	$	10,248	Retirement benefit expense (1)

_____________________

(1) There is no income tax benefit associated with the quarters and six months ended June 28, 2020, or June 30, 2019, due to the recognition of a valuation allowance.

Summary of the restricted stock units ("RSUs") activity


		Weighted
		Average Grant
		Date Fair
	RSUs	Value
Nonvested — December 29, 2019	413,466	$	7.00
Vested	(217,958)	$	7.46
Forfeited	(975)	$	6.46
Nonvested — June 28, 2020	194,533	$	6.48

Summary of the stock appreciation rights ("SARs") activity

The following table summarizes the stock appreciation rights (“SARs”) activity during the six months ended June 28, 2020:


		Weighted		Aggregate
		Average		Intrinsic Value
	SARs	Exercise Price		(in thousands)
Outstanding December 29, 2019	88,875	$	31.61	$	—
Expired	(9,125)	$	33.78
Outstanding June 28, 2020	79,750	$	31.36	$	—

Summary of stock-based compensation expense


	Quarters Ended				Six Months Ended
	June 28,		June 30,		June 28,		June 30,
(in thousands)	2020		2019		2020		2019
Stock-based compensation expense	$	368	$	303	$	774	$	966

Summary of anti-dilutive stock options


	Quarters Ended		Six Months Ended
	June 28,	June 30,	June 28,	June 30,
(shares in thousands)	2020	2019	2020	2019
Anti-dilutive common stock equivalents	260	511	310	464